Speakers
Gerald Capraro, PhD, D(ABMM)
Carolinas Pathology Group, Charlotte, NC

Dr. Capraro is medical director of the Clinical Microbiology laboratory for Atrium Health in Charlotte, NC. He earned his PhD in Microbiology & Immunology from Wake Forest University and completed fellowship training at the University of Nebraska Medical Center. He is Board certified in Medical and Public Health Microbiology. He is actively involved in the American Society for Microbiology, the Pan-American Society for Clinical Virology, and CLSI. He serves as a reviewer for the Journal of Clinical Microbiology and as a member of the editorial board for LabMedicine. He is on the programming board for the SouthEastern Association for Clinical Microbiology annual meeting and has recently been elected President-Elect of SEACM.

 

Disclosures: I received honoraria from BioFire, Roche, DiaSorin Molecular, QuantaMatrix, Quidel.

 

Stephanie Mitchell, PhD, D(ABMM)
University of Pittsburgh Medical Center, Pittsburgh, PA

Dr. Stephanie Mitchell is the Medical Director of Clinical Microbiology at the Children’s Hospital of Pittsburgh of UPMC, Assistant Director of Clinical Microbiology at UPMC Presbyterian Hospital and Assistant Professor in the Department of Pathology at University of Pittsburgh School of Medicine. Her research interests include the development of molecular infectious disease diagnostics and novel applications of Next Generation Sequencing for diagnostic assays in the clinical laboratory.

 

Disclosures: I am a paid consultant/employee for GenMark Diagnostics Scientific Advisory Board.

 

Ryan F. Relich, PhD, D(ABMM), MLS(ASCP)SM
Indiana University School of Medicine, Indianapolis, IN

Dr. Relich is a board-certified clinical microbiologist who is passionately interested in all facets of diagnostic microbiology and laboratory medicine, especially the development of novel diagnostics, including those for high-consequence pathogens, laboratory directorship, infectious disease epidemiology and pathology, and emerging virus ecology and discovery. In his current academic position at the Indiana University (IU) School of Medicine, he is actively involved in fellow, resident, and student teaching, and research involving in vitro diagnostic product development and clinical trials, and, most recently, the ecology of emerging zoonotic viruses such as Heartland virus, Bourbon virus, hantaviruses, and many others. As an employee of IU Health, Dr. Relich serves as the Medical Director of the IU Health Special Pathogens Unit Laboratory, Associate Medical Director of the Divisions of Clinical Microbiology and Molecular Pathology, and Section Director of Clinical Virology. Dr. Relich also serves as Section Director, Clinical Microbiology and Serology for Eskenazi Health, a community healthcare system located in central Indiana. He is immensely interested in pandemic preparedness, novel virus discovery and characterization, and establishing best practices for manipulating highly infectious clinical specimens such as those from Ebola patients, among many other things.

 

Disclosures: I am a paid consultant/employee for NaviDx Consulting. I received honoraria from
Illinois Society for Microbiology BioFire Diagnostics.

 

Elitza Theel, PhD, D(ABMM)
Mayo Clinic, Rochester, MN

Dr. Elli Theel received her PhD in Medical Microbiology and Immunology at the University of Wisconsin-Madison and subsequently completed a Clinical Microbiology fellowship at the Mayo Clinic in Rochester, MN. She is certified by the American Board of Medical Microbiology and is currently the Director of the Infectious Diseases Serology Laboratory and Co-Director of the Vector-Borne Diseases Service Line at Mayo Clinic. She is also an Associated Professor of Laboratory Medicine and Pathology, also at Mayo Clinic.

 

Disclosures: Nothing to disclose.

Association Management Software Powered by YourMembership  ::  Legal